- 期刊
Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
延伸閱讀
- Shaygannejad, V., Janghorbani, M., Ashtari, F., & Dehghan, H. (2012). Effects of Adjunct Low-Dose Vitamin D on Relapsing-Remitting Multiple Sclerosis Progression: Preliminary Findings of a Randomized Placebo-Controlled Trial. Multiple Sclerosis International, 2012(), 66-72. https://doi.org/10.1155/2012/452541
- Kirkland, M. C., Wallack, E. M., Rancourt, S. N., & Ploughman, M. (2015). Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls. Multiple Sclerosis International, 2015(), 112-118. https://doi.org/10.1155/2015/650645
- Zivadinov, R., Tekwe, C., Bergsland, N., Dolezal, O., Havrdova, E., Krasensky, J., Dwyer, M. G., Seidl, Z., Ramasamy, D. P., Vaneckova, M., & Horakova, D. (2013). Bimonthly Evolution of Cortical Atrophy in Early Relapsing-Remitting Multiple Sclerosis over 2 Years: A Longitudinal Study. Multiple Sclerosis International, 2013(), 57-64. https://doi.org/10.1155/2013/231345
- Rabiei, L., Abedi, H., Abedi, P., Zarea, K., & Masoudi, R. (2017). Perspectives and Experiences Related to Help-Seeking Behaviors: A Content Analysis Study of Iranian Patients With Multiple Sclerosis. The Journal of Nursing Research, 25(3), 251-259. https://doi.org/10.1097/jnr.0000000000000216
- Yamamoto, D., & Campbell, J. D. (2012). Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature. Autoimmune Diseases, 2012(), 375-387. https://doi.org/10.1155/2012/784364